Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China T-Cell Immunotherapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China T-Cell Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by T-Cell Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Takara Bio
Juno Therapeutics
Cellectis
Adaptimmune
Novartis
Unum Therapeutics
Altor Bioscience Corporation
Kite Pharma
By Type:
CAR-T
TCR
TIL Therapies
By End-User:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of T-Cell Immunotherapy Market
-
1.3 Market Segment by Type
-
1.3.1 China T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027
-
1.3.2 China T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2016 to 2027
-
1.3.3 China T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
1.4.2 China T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
1.4.3 China T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
1.4.4 China T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2016 to 2027
-
1.4.5 China T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2016 to 2027
-
1.4.6 China T-Cell Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of T-Cell Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of T-Cell Immunotherapy by Major Types
-
3.4.1 Market Size and Growth Rate of CAR-T
-
3.4.2 Market Size and Growth Rate of TCR
-
3.4.3 Market Size and Growth Rate of TIL Therapies
4 Segmentation of T-Cell Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of T-Cell Immunotherapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of T-Cell Immunotherapy in Stomach Cancer
-
4.4.2 Market Size and Growth Rate of T-Cell Immunotherapy in Lung Cancer
-
4.4.3 Market Size and Growth Rate of T-Cell Immunotherapy in Colorectal Cancer
-
4.4.4 Market Size and Growth Rate of T-Cell Immunotherapy in Esophagus Cancer
-
4.4.5 Market Size and Growth Rate of T-Cell Immunotherapy in Pancreatic Cancer
-
4.4.6 Market Size and Growth Rate of T-Cell Immunotherapy in Others
5 Market Analysis by Regions
-
5.1 China T-Cell Immunotherapy Production Analysis by Regions
-
5.2 China T-Cell Immunotherapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China T-Cell Immunotherapy Landscape Analysis
-
6.1 North China T-Cell Immunotherapy Landscape Analysis by Major Types
-
6.2 North China T-Cell Immunotherapy Landscape Analysis by Major End-Users
7 Central China T-Cell Immunotherapy Landscape Analysis
-
7.1 Central China T-Cell Immunotherapy Landscape Analysis by Major Types
-
7.2 Central China T-Cell Immunotherapy Landscape Analysis by Major End-Users
8 South China T-Cell Immunotherapy Landscape Analysis
-
8.1 South China T-Cell Immunotherapy Landscape Analysis by Major Types
-
8.2 South China T-Cell Immunotherapy Landscape Analysis by Major End-Users
9 East China T-Cell Immunotherapy Landscape Analysis
-
9.1 East China T-Cell Immunotherapy Landscape Analysis by Major Types
-
9.2 East China T-Cell Immunotherapy Landscape Analysis by Major End-Users
10 Northeast China T-Cell Immunotherapy Landscape Analysis
-
10.1 Northeast China T-Cell Immunotherapy Landscape Analysis by Major Types
-
10.2 Northeast China T-Cell Immunotherapy Landscape Analysis by Major End-Users
11 Southwest China T-Cell Immunotherapy Landscape Analysis
-
11.1 Southwest China T-Cell Immunotherapy Landscape Analysis by Major Types
-
11.2 Southwest China T-Cell Immunotherapy Landscape Analysis by Major End-Users
12 Northwest China T-Cell Immunotherapy Landscape Analysis
-
12.1 Northwest China T-Cell Immunotherapy Landscape Analysis by Major Types
-
12.2 Northwest China T-Cell Immunotherapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Takara Bio
-
13.1.1 Takara Bio Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Juno Therapeutics
-
13.2.1 Juno Therapeutics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Cellectis
-
13.3.1 Cellectis Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Adaptimmune
-
13.4.1 Adaptimmune Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis
-
13.5.1 Novartis Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Unum Therapeutics
-
13.6.1 Unum Therapeutics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Altor Bioscience Corporation
-
13.7.1 Altor Bioscience Corporation Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Kite Pharma
-
13.8.1 Kite Pharma Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2016 to 2027
-
Figure China T-Cell Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of T-Cell Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of T-Cell Immunotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of T-Cell Immunotherapy by Different Types from 2016 to 2027
-
Table Consumption Share of T-Cell Immunotherapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of CAR-T
-
Figure Market Size and Growth Rate of TCR
-
Figure Market Size and Growth Rate of TIL Therapies
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of T-Cell Immunotherapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of T-Cell Immunotherapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Stomach Cancer
-
Figure Market Size and Growth Rate of Lung Cancer
-
Figure Market Size and Growth Rate of Colorectal Cancer
-
Figure Market Size and Growth Rate of Esophagus Cancer
-
Figure Market Size and Growth Rate of Pancreatic Cancer
-
Figure Market Size and Growth Rate of Others
-
Table China T-Cell Immunotherapy Production by Regions
-
Table China T-Cell Immunotherapy Production Share by Regions
-
Figure China T-Cell Immunotherapy Production Share by Regions in 2016
-
Figure China T-Cell Immunotherapy Production Share by Regions in 2021
-
Figure China T-Cell Immunotherapy Production Share by Regions in 2027
-
Table China T-Cell Immunotherapy Consumption by Regions
-
Table China T-Cell Immunotherapy Consumption Share by Regions
-
Figure China T-Cell Immunotherapy Consumption Share by Regions in 2016
-
Figure China T-Cell Immunotherapy Consumption Share by Regions in 2021
-
Figure China T-Cell Immunotherapy Consumption Share by Regions in 2027
-
Table North China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table North China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure North China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure North China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure North China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table North China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table North China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure North China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure North China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Central China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Central China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Central China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Central China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Central China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Central China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Central China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Central China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Central China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table South China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table South China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure South China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure South China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure South China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table South China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table South China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure South China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure South China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table East China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table East China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure East China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure East China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure East China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table East China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table East China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure East China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure East China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Northeast China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northeast China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Northeast China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northeast China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Southwest China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Southwest China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Southwest China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Southwest China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Northwest China T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northwest China T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Northwest China T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northwest China T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Takara Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio
-
Figure Sales and Growth Rate Analysis of Takara Bio
-
Figure Revenue and Market Share Analysis of Takara Bio
-
Table Product and Service Introduction of Takara Bio
-
Table Company Profile and Development Status of Juno Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics
-
Figure Sales and Growth Rate Analysis of Juno Therapeutics
-
Figure Revenue and Market Share Analysis of Juno Therapeutics
-
Table Product and Service Introduction of Juno Therapeutics
-
Table Company Profile and Development Status of Cellectis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis
-
Figure Sales and Growth Rate Analysis of Cellectis
-
Figure Revenue and Market Share Analysis of Cellectis
-
Table Product and Service Introduction of Cellectis
-
Table Company Profile and Development Status of Adaptimmune
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune
-
Figure Sales and Growth Rate Analysis of Adaptimmune
-
Figure Revenue and Market Share Analysis of Adaptimmune
-
Table Product and Service Introduction of Adaptimmune
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Unum Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unum Therapeutics
-
Figure Sales and Growth Rate Analysis of Unum Therapeutics
-
Figure Revenue and Market Share Analysis of Unum Therapeutics
-
Table Product and Service Introduction of Unum Therapeutics
-
Table Company Profile and Development Status of Altor Bioscience Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor Bioscience Corporation
-
Figure Sales and Growth Rate Analysis of Altor Bioscience Corporation
-
Figure Revenue and Market Share Analysis of Altor Bioscience Corporation
-
Table Product and Service Introduction of Altor Bioscience Corporation
-
Table Company Profile and Development Status of Kite Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma
-
Figure Sales and Growth Rate Analysis of Kite Pharma
-
Figure Revenue and Market Share Analysis of Kite Pharma
-
Table Product and Service Introduction of Kite Pharma
-
